Cognition Therapeutics (CGTX) Debt Ratio (2020)
Cognition Therapeutics (CGTX) posted quarterly Debt Ratio of 0.06 for Q4 2020.
Cognition Therapeutics (CGTX) Debt Ratio (2020) Analysis & Trends
Cognition Therapeutics (CGTX) has reported Debt Ratio for 1 consecutive years, with 0.06 the latest figure, recorded in Q4 2020.
- In Q4 2020, Debt Ratio changed N/A year-over-year to 0.06; the TTM figure through Dec 2020 stood at 0.06 (changed N/A YoY), while the FY2020 annual figure was 0.06, changed N/A from the prior year.
- Debt Ratio steadied at 0.06 in Q4 2020 per CGTX's latest filing.
- Across five years, Debt Ratio topped out at 0.06 in Q4 2020 and bottomed at 0.06 in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.61 Bn | 131.75 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.70 Bn | 78.71 Bn | 3.93 Bn | 0.05 |
| 3 | Argenx Se | 65.28 Bn | 60.09 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.14 Bn | 54.00 Bn | 52.00 Mn | 0.05 |
| 5 | BeOne Medicines | 42.13 Bn | 37.03 Bn | 1.53 Bn | 0.12 |
| 6 | Alnylam Pharmaceuticals | 31.83 Bn | 28.52 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.07 Bn | 9.68 Bn | 668.28 Mn | 0.03 |
| 8 | Insmed | 27.54 Bn | 26.38 Bn | 358.27 Mn | 0.26 |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - | 0.47 |
| 10 | Cognition Therapeutics | 90.17 Mn | 90.17 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 0.06 |